Global Single Cell Analysis Market is estimated to be US$ 8.4 billion by 2030 with a CAGR of 13.1%
The Global Single-Cell Analysis Market accounted for US$ 2.5 billion in 2020 and is estimated to be US$ 8.4 billion by 2030 and is anticipated to register a CAGR of 13.1%. In the field of cell science, single-cell investigation is the investigation of genomics, transcriptomics, proteomics, metabolomics and cell–cell connections at the single cell level. Because of the heterogeneity seen in both eukaryotic and prokaryotic cell populaces, investigating a solitary cell makes it conceivable to find instruments not seen when contemplating a mass populace of cells. Advances, for example, fluorescence-enacted cell arranging (FACS) permit the exact confinement of chose single cells from complex examples, while high throughput single cell parceling advances, empower the concurrent atomic investigation of hundreds or thousands of single unsorted cells; this is especially helpful for the examination of transcriptome variety in genotypically indistinguishable cells, permitting the meaning of in any case imperceptible cell subtypes. The advancement of new advances is expanding our capacity to investigate the genome and transcriptome of single cells, just as to evaluate their proteome and metabolome. Mass spectrometry strategies have become significant scientific devices for proteomic and metabolomic examination of single cells.
The report " Global Single Cell Analysis Market, By Cell Type (Human, Animal, and Microbial), By Technique (Flow Cytometry, Next-generation Sequencing, PCR, Microscopy, Mass Spectroscopy, and Others), By Application (Research (Cancer, Immunology, Neurology, Stem Cell, and Others), and Medical (Non-Invasive Prenatal Diagnosis, In Vitro Fertilization, Circulating Tumor Cell, and Detection)), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, and Hospital and Diagnostic Laboratories), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
In June 2021, Immudex announces the launch of the new U-Load Dextramer product line that allows scientists to swiftly assemble their own sensitive antigen-specific Dextramer reagents for immune monitoring directly in the lab using loadable MHC class I easYmer and the novel loadable MHC class II monomers, U-Load MHC II.
In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been designed for consolidated targeted DNA and RNA enrichment and analyses.
In July 2019, QIAGEN partnered with Illumina with the aim to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits.
To know the upcoming trends and insights prevalent in this market, click the link below:
|Related Link: Click here to visit item owner's website (0 hit)|
|Target State: All States|
Target City : All Cities
Last Update : Oct 11, 2021 4:38 AM
Number of Views: 25
|Item Owner : NileshDM|
Contact Phone: 7775049802
|Friendly reminder: Click here to read some tips.|